Malaysia's E-cigarette Legalization Still in Question

Aug.09.2022
Malaysia's E-cigarette Legalization Still in Question
The legalization of e-cigarettes sales in Malaysia faces challenges as the proposed "Generation End" anti-smoking bill is under review.

The main advocacy organization in the region, MOVE (Malaysia Vape Entity), has stated that the legalization of electronic cigarette sales in Malaysia still faces challenges, following unexpected turns prior to the Parliamentary elections.


Samsul Kamal Ariffin, the CEO of MOVE, has announced that the proposed "end intergenerational smoking" bill has been referred to a special committee in parliament for further scrutiny, which he considers to be positive news.


We are concerned that electronic cigarettes will be included in this anti-smoking bill, which will result in strict regulations and criminalization of consumers and retailers. Members of the specialized committee now have the opportunity to remove electronic cigarettes and non-combustible products from the legislation and treat them as tools for harm reduction in a completely different manner," said Mr. Alifin.


The date for Malaysia's general election is yet to be confirmed. However, if the next parliamentary session is held earlier, a select committee will take action to prepare a statement on its proposed amendments. MOVE will have a representative serving as a member of this special committee.


Similar to current legislation in New Zealand, Malaysia's proposed "intergenerational end" bill seeks to ban the sale of cigarettes and tobacco products to anyone born after 2007. However, unlike New Zealand, Malaysia's Health Minister also suggests adding electronic cigarette products to the intergenerational ban.


If Malaysia aims to reduce its overall smoking rate to below 5% by 2040, a ban on electronic cigarettes would not be able to achieve that goal. New Zealand has a smoking rate that is less than half of ours because they have become increasingly strict on smoking while only regulating the retail channels of adult e-cigarette products. New Zealand will likely achieve a smoke-free status at least a generation earlier than us because their approach to smoking and e-cigarette use is vastly different. If we want to save lives, Malaysia must do the same," he said.


In April, advocates for tobacco harm reduction (THR) were encouraged when regulations for electronic cigarette devices were announced to take effect on August 3rd. They had been lobbying for this to happen before the legalization of electronic cigarette sales, as have other THR supporters for many years.


We were concerned when the Health Minister proposed the "legacy of generations" bill on August 2nd and intended to pass it before parliament adjourned. Fortunately, enough members of parliament fought back, and the select committee or the next parliament can now regulate e-cigarettes through separate legislation. This is what needs to happen, and I believe it will.


As evidenced by 70 countries, the THR method is effective. Banning e-cigarettes will only harm smokers. Regulating e-cigarettes will provide a viable and less harmful alternative for smokers, not to mention much-needed tax revenue for Malaysia," said Mr. Alifin.


For the past decade, it has been a black market for electronic cigarette users in Malaysia, with unapproved products being untaxed and no safety guarantees for local consumers regarding product standards.


According to Mr. Alifin, providing a feasible, safe, and legal way for the 21% of Malaysians who smoke to improve their health and well-being is crucial. Electronic cigarettes are believed to be 95% less harmful than combustible tobacco. Making safer nicotine products legally available is the only way to significantly reduce Malaysia's unnecessary high smoking rates and save tens of thousands of lives each year.


The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has endorsed the legalization and regulation of e-cigarette sales in Malaysia, believing it will lead to a significant reduction in smoking rates.


MOVE continues to work with political figures and health officials in Malaysia to provide them with necessary information and support to effectively tackle the country's smoking epidemic. CAPHRA believes that the unsuccessful ban on e-cigarettes in Malaysia will be lifted in the next few months and there will be no turning back, said Nancy Lucas, CAPHRA's Executive Coordinator.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS. 2FIRSTS also cannot confirm the truthfulness or accuracy of the content of the article. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in translation proficiency, the translated article may not fully capture the original author's intended meaning. Therefore, please refer to the original text for accuracy.


2FIRSTS aligns completely with the stance and position of the Chinese government on any domestic, cross-strait, or foreign related issues.


The compilation of information is owned by the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
2Firsts Hosts China Market Forum at InterTabac as Global Industry Attention to China’s Tobacco Sector Deepens
On September 16, 2Firsts hosted a China-focused industry forum during InterTabac in Dortmund, bringing together more than 30 participants from North America, Europe, India, South Korea and other markets. The session covered traditional tobacco, next-generation products, exports, technology, regulation and supply chains, while examining how China’s tobacco sector operates, where its transformation may be heading, and why its growing role matters increasingly to companies across the global tobacco and nicotine industry.
Sep.21
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03